Discovery of Potent and Selective Agonists of δ Opioid Receptor by Revisiting the "Message-Address" Concept

被引:16
作者
Shen, Qing [1 ]
Qian, Yuanyuan [1 ]
Huang, Xiaoqin [2 ,3 ]
Xu, Xuejun [4 ]
Li, Wei [1 ]
Liu, Jinggen [4 ]
Fu, Wei [1 ]
机构
[1] Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 201203, Peoples R China
[2] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA
[3] Rice Univ, Ctr Res Comp, Houston, TX 77005 USA
[4] Chinese Acad Sci, Shanghai Inst Mat Medica, Shanghai 201203, Peoples R China
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2016年 / 7卷 / 04期
基金
美国国家科学基金会; 中国国家自然科学基金; 上海市科技启明星计划;
关键词
delta opioid receptor; agonist; affinity; selectivity; molecular docking; NEUROPATHIC PAIN; ANTAGONISTS; MODEL;
D O I
10.1021/acsmedchemlett.5b00423
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The classic "message-address" concept was proposed to address the binding of endogenous peptides to the opioid receptors and was later successfully applied in the discovery of the first nonpeptide 6 opioid receptor (DOR) antagonist naltrindole. By revisiting this concept, and based on the structure of tramadol, we designed a series of novel compounds that act as highly potent and selective agonists of DOR among which (-)-6j showed the highest affinity (K-i = 2.7 nM), best agonistic activity (EC50 = 2.6 nM), and DOR selectivity (more than 1000-fold over the other two subtype opioid receptors). Molecular docking studies suggest that the "message" part of (-)-6j interacts with residue Asp128(3.32) and a neighboring water molecule, and the "address" part of (-)-6j packs with hydrophobic residues Leu300(7.33), Val281(6.55), and Trp284(6.58), rendering DOR selectivity. The discovery of novel compound (-)-6j, and the obtained insights into DOR-agonist binding will help us design more potent and selective DOR agonists.
引用
收藏
页码:391 / 396
页数:6
相关论文
共 19 条
[1]  
Brandt MR, 2001, J PHARMACOL EXP THER, V296, P939
[2]   Behavioral effects of δ-opioid receptor agonists:: Potential antidepressants? [J].
Broom, DC ;
Jutkiewicz, EM ;
Rice, KC ;
Traynor, JR ;
Woods, JH .
JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 90 (01) :1-6
[3]   Convulsant activity of a non-peptidic δ-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats [J].
Broom, DC ;
Jutkiewicz, EM ;
Folk, JE ;
Traynor, JR ;
Rice, KC ;
Woods, JH .
PSYCHOPHARMACOLOGY, 2002, 164 (01) :42-48
[4]   SELECTIVE OPIOID RECEPTOR AGONISTS MODULATE MECHANICAL ALLODYNIA IN AN ANIMAL-MODEL OF NEUROPATHIC PAIN [J].
DESMEULES, JA ;
KAYSER, V ;
GUILBAUD, G .
PAIN, 1993, 53 (03) :277-285
[5]   Antihyperalgesic effects of δ opioid agonists in a rat model of chronic inflammation [J].
Fraser, GL ;
Gaudreau, GA ;
Clarke, PBS ;
Ménard, DP ;
Perkins, MN .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (08) :1668-1672
[6]   Affinity, potency and efficacy of tramadol and its metabolites at the cloned human μ-opioid receptor [J].
Gillen, C ;
Haurand, M ;
Kobelt, DJ ;
Wnendt, S .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 362 (02) :116-121
[7]   Structure of the δ-opioid receptor bound to naltrindole [J].
Granier, Sebastien ;
Manglik, Aashish ;
Kruse, Andrew C. ;
Kobilka, Tong Sun ;
Thian, Foon Sun ;
Weis, William I. ;
Kobilka, Brian K. .
NATURE, 2012, 485 (7398) :400-U171
[8]   Role of opioids in acute and delayed preconditioning [J].
Gross, GJ .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (07) :709-718
[9]  
Hill MP, 2000, DRUG NEWS PERSPECT, V13, P261
[10]   Development and validation of a genetic algorithm for flexible docking [J].
Jones, G ;
Willett, P ;
Glen, RC ;
Leach, AR ;
Taylor, R .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (03) :727-748